Does Surgeon Volume Matter? What 30 Years of Research Actually Shows

By Trusted Surgeon Team — 2026-08-04

Photo: Delhi Eye Centre / Pexels

Photo: DΛVΞ GΛRCIΛ / Pexels

Does Surgeon Volume Matter? What 30 Years of Research Actually Shows

Yes — surgeon volume matters, and it is one of the most consistently replicated findings in surgical outcomes research. Across three decades, dozens of studies, and millions of patients, higher procedure-specific surgeon volume has been associated with lower mortality, fewer complications, fewer revisions, and shorter hospital stays. The effect appears in hip replacement, heart bypass, and nearly every major procedure studied. It is not the only thing that matters — researchers are careful to call volume an imperfect marker on its own — but if you ask a single question before surgery, "how many of these do you do each year?" is the one the evidence supports. Here is what the research actually shows, study by study.

This page is maintained by Trusted Surgeon, an independent surgeon-selection advisory serving California patients. We summarize the peer-reviewed literature below with links to every source.

Where did the surgeon-volume finding come from?

The modern evidence base starts with two landmark New England Journal of Medicine studies. In 2002, Birkmeyer and colleagues analyzed 2.5 million Medicare operations — including heart bypass — and found that mortality fell as hospital volume rose (NEJM 2002;346:1128–37). The follow-up question was whether the hospital or the surgeon drove the effect. In 2003, the same group found that surgeon volume was strongly associated with operative mortality across eight major procedures — and explained a large share of the hospital-volume effect (NEJM 2003;349:2117–27).

Twenty years of research since has refined, replicated, and extended that finding. It has not overturned it.

What does the research show for hip replacement surgeons?

The hip replacement literature is unusually deep and unusually consistent:

• BMJ, 2014 — 37,881 hip replacements in Ontario. Patients of surgeons performing 35 or fewer hip replacements per year had a 1.9% dislocation rate within two years, versus 1.3% for higher-volume surgeons — and a 1.5% early revision rate versus 1.0% (Ravi et al., BMJ 2014;348:g3284).
• Hip International, 2025 — 283,888 hip replacements in New York State (2010–2020). High-volume surgeons (over 150 cases per year) had periprosthetic joint infection rates of 0.5%, versus 1.0% for low-volume surgeons. Low volume was associated with 1.87× the odds of infection and a 1.3× hazard of revision (Di Pauli von Treuheim et al., Hip International 2025).
• JBJS, 2001 — Medicare hip replacements. Higher-volume surgeons and hospitals were associated with lower dislocation rates and lower mortality (Katz et al., JBJS Am 2001;83:1622–9).
• Arthritis & Rheumatism, 2003. The benefit extends beyond avoiding complications: patients of higher-volume providers reported better function and satisfaction three years after hip replacement (Katz et al., 2003).
• Journal of Arthroplasty, 2018 — systematic review. Across the pooled literature, higher-volume hip replacement surgeons were consistently associated with fewer complications, shorter stays, and lower revision rates (Malik et al., J Arthroplasty 2018).
• Journal of Arthroplasty, 2024 — 5,106 US surgeons. A nationwide analysis again associated lower surgeon volume with higher dislocation rates (J Arthroplasty 2024).
• Journal of Arthroplasty, 2023 — patient-reported outcomes. In the American Joint Replacement Registry, surgeon and hospital volume were linked to differences in how much patients actually improved after surgery, by their own report (J Arthroplasty 2023).

Two decades apart, different countries, different registries, different endpoints — the same direction every time.

What does the research show for heart bypass (CABG) surgeons?

• Circulation, 2003 — 57,150 bypass surgeries in New York's cardiac registry. Patients of surgeons performing 125 or more CABGs per year at hospitals performing 600 or more had a risk-adjusted mortality of 1.89%, versus 2.67% otherwise (Hannan et al., Circulation 2003;108:795–801). New York's registry matters because, like California's, it is one of the few that reports at the surgeon level.
• JAMA, 2004 — STS national database. Higher-volume CABG programs had modestly lower mortality — with the important nuance that volume alone did not identify every high or low performer (Peterson et al., JAMA 2004;291:195–201).
• PLOS ONE, 2021 — national CABG study. Researchers identified minimum surgeon and hospital volume thresholds below which mortality and hospital stays were measurably higher (Chou et al., PLOS ONE 2021;16:e0249750).
• Hospital-level evidence points the same way. Lower-volume hospitals showed higher adjusted CABG mortality in Medicare data (Rathore et al., Ann Surg 2004;239:110–117 — ⚠ bank lists "PubMed" without ID; verify exact link before publish), and low hospital CABG volume was associated with higher in-hospital mortality (adjusted OR 1.39) in a 2016 analysis (Kim et al., JTCVS 2016;151:1686–92). These measure the hospital, not the surgeon — both belong on your checklist.

Is volume the whole story?

No — and the researchers themselves say so. A 2010 analysis in the Journal of Thoracic and Cardiovascular Surgery found volume associated with mortality and quality, but modestly: volume alone is an imperfect quality marker (Shahian et al., JTCVS 2010;139:273–82). The JAMA STS study found the same: some lower-volume surgeons perform excellently, and some high-volume surgeons don't.

Two refinements matter for patients:

• Volume is procedure-specific — and even approach-specific. A Dutch registry study of 15,875 hip replacements found the anterior-approach learning curve runs to roughly 100 cases (Peters et al., Acta Orthop 2022;93:775–782), and a 2024 population study found lower-volume anterior-approach surgeons had higher complication rates (Acta Orthopaedica 2024). "I do a lot of hip surgery" is not the same as "I do a lot of your hip surgery."
• Both surgeon and hospital volume count. A 2022 registry analysis found each independently associated with joint replacement outcomes (JAAOS 2022) — so check the surgeon and the building.

This is why volume is the starting question, not the verdict. Readmission rates, length of stay, risk-adjusted mortality, licensing history, and case mix complete the picture — it's the combination that separates a data-driven choice from a lucky one.

How many surgeries per year is "high volume"?

The honest answer: research reports thresholds, not magic numbers, and they vary by study.

Read these as directional: the associations strengthen as annual, procedure-specific volume rises. A surgeon comfortably above the studied thresholds — in your exact procedure and approach — is what the evidence points toward.

How do I find out a surgeon's volume?

Ask directly — "How many of my specific procedure did you personally perform last year?" — and verify where you can. CMS publishes Medicare procedure counts by physician; California publishes surgeon-level risk-adjusted heart bypass mortality through CCORP/HCAI, something almost no other state does. Our data-driven guide to finding a trustworthy surgeon in California walks through every public source, and our methodology page shows how we combine them. The public data typically lags 1–2 years — a real limitation worth knowing about any source, including ours.

FAQ

Does surgeon volume really affect outcomes? Yes. Across three decades of peer-reviewed research — including registry studies of hundreds of thousands of patients — higher procedure-specific surgeon volume has been consistently associated with lower mortality, fewer complications, and fewer revisions. Researchers describe the association as robust but imperfect: volume is the strongest single publicly available signal, not a guarantee.

What is a high-volume hip replacement surgeon? Studies have used different cutoffs: one major study found worse outcomes below roughly 35 cases per year, while another defined high-volume as more than 150 per year. Directionally, more annual cases of your specific procedure and approach is associated with better results.

What is a high-volume heart bypass surgeon? New York registry research associated surgeons performing 125+ CABGs per year at high-volume hospitals with risk-adjusted mortality of 1.89%, versus 2.67% otherwise.

Is a high-volume surgeon always the better choice? Not automatically. Volume alone doesn't identify every high or low performer — which is why readmission rates, length of stay, risk-adjusted outcomes, and licensing records belong in the decision alongside it.

Does hospital volume matter too? Yes. Hospital volume and surgeon volume are each independently associated with outcomes in both cardiac and joint replacement research. Check both.

Trusted Surgeon provides informational summaries and data analysis to support your decision-making. We do not diagnose medical conditions, recommend treatments, or provide medical care. Always consult board-certified physicians regarding your care.

Facing a hip or heart bypass decision in California? Get Your Curated Surgeon Shortlist — 3 named surgeons, the evidence for each, in 24 hours. See How We Evaluate Surgeons →

https://trusted-surgeon.com/blog/does-surgeon-volume-matter-what-30-years-of-research-actually-shows